Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis-Reference-Cited by-同舟云学术

Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis

Published:2013-02-21 Issue:8 Volume:121 Page:1477-1478
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Michel L.¹,Jean-Louis F.¹,Begue E.¹,Bensussan A.¹,Bagot M.²

Affiliation:

1. Inserm Unit 976, Hospital Saint-Louis and Université Paris Diderot, Sorbonne Paris Cité, Laboratory UMRS 976, Paris, France

2. Inserm Unit 976, Hospital Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité, Laboratory UMRS 976, and Department of Dermatology, Assistance Publique–Hôpitaux de Paris, Hospital Saint-Louis, Paris, France

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/8/1477/1369802/zh800813001477.pdf

Reference10 articles.

1. Inducible expression and pathophysiological functions of T-plastin in cutaneous T-cell lymphoma.;Bégué;Blood,2012

2. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma.;Kari;J Exp Med,2003

3. Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy.;Nebozhyn;Blood,2006

4. Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.;Booken;Leukemia,2008

5. T-plastin (PLS3) gene expression differentiates Sezary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression.;Tang;Br J Dermatol,2010

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delving into the Metabolism of Sézary Cells: A Brief Review;Genes;2024-05-17

2. The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas;Frontiers in Oncology;2023-11-08

3. mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy;Cancers;2023-09-04

4. Mycosis fungoides and Sézary syndrome;Blood Research;2023-04-30

5. Characterizing the Spectrum of Epigenetic Dysregulation Across Lymphoid Malignancies;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15